Overview


Increasing incidences of obesity and diabetes, environmental effects like air pollution and changing lifestyle are some integral factors leading to infertility in both women and men. According to the data reported by WHO, over 600 million people are identified as overweight and over 2 million people around the world are diagnosed with obesity. Additionally, workplace stress is another contributing factor for increase in infertility cases.
Hefty investments in research and development has created numerous opportunities for the market to prosper. In a recent study, a female mouse successfully conceives and gave birth to an offspring which was healthy and this was done with a synthetic ovary that was created using a 3D printer. This is considered as a breakthrough research thus leading to eminent infertility treatment for women diagnosed with cancer. One of the co-authors, Alexander Rutz, states that these synthetic ovaries are known as biosynthetic organs as they comprise ovarian cells as well as gelatin. The naturally present ovary was removed and replaced by the biosynthetic ovary so that the mouse shall experience its natural ovulation cycle.
Female infertility treatment segment is projected to account for the largest market share during the forecast period. There has been a rise in the female infertility rates, increasing awareness among women regarding infertility treatments, increase in the number of fertility centres and availability of multiple treatment options are integral factors contributing to the market growth.
Hospitals and surgical clinics segment is expected to exhibit noteworthy growth over the forecast period. Hospitals are firmly bolstered by other departments like neonatal intensive care units. Additionally, hospitals offer a comprehensive maternity treatment even after childbirth. Governmental initiatives to increase the number of multispecialty hospitals with departments to perform infertility treatment procedures like IVF coupled with the increasing number of surgical centres with provisions of surgical procedures for the treatment of infertility is projected to proliferate the market.
  • Cook Group Incorporated
  • Esco Micro Pte. Ltd.
  • Genea Limited
  • Hamilton Throne, Ltd.
  • Ihmedical A/S
  • Irvine Scientific (A Member of Jx Holdings Group)
  • IVFTech Aps
  • Kitazato Corporation
  • Medgyn Products, Inc.
  • Rocket Medical PLC
  • Somatex Medical Technologies GmbH
  • The Baker Company, Inc.
  • The Cooper Companies, Inc.
  • Thermo Fisher Scientific
  • Vitrolife Ab
  • Zeiss Group

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

• Equipment
  o Microscopes
  o Imaging Systems
  o Sperm Analyzer Systems
  o Ovum aspiration Pumps
  o Micromanipulator Systems
  o Incubators
  o Gas Analyzers
  o Laser Systems
  o Cryo Systems
• Media & Consumables
• Accessories

By Procedure

• In Vitro Fertilization
• Artificial Insemination
  o Intrauterine Insemination
  o Intracervical Insemination
  o Intratubal Insemination
• Fertility Surgery
  o Laparoscopy
  o Hysteroscopy
  o Myomectomy
  o Laparotomy
  o Tubal Ligation Reversal
  o Varicocelectomy
  o Microsurgical Reconstruction
  o Vasovasostomy
  o Vasoepididymostomy
• Others

By Patient Type

  • Female Infertility Treatment
  • Male Infertility Treatment

By End User

  • Fertility Centres
  • Hospitals and Surgical Clinics
  • Research Institutes
  • Cryobanks

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

 
  • Tier 1 players- established companies in the market with a major market share  
  • Tier 2 players 
  • Emerging players which are growing rapidly 
  • New Entrants

 
  • Stressful lifestyle and consumption of unhealthy products like tobacco and alcohol are primary reasons of infertility and its soaring rise has increased the demand for market
  • The high costs of treatments and societal pressures on patients can significantly affect the market growth especially in the developing economies

 
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Infertility Treatment Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Global Infertility Treatment Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Infertility Treatment Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Infertility Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Infertility Treatment Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Equipment
         1.1 . Microscopes
         1.2 . Imaging Systems
         1.3 . Sperm Analyzer Systems
         1.4 . Ovum aspiration Pumps
         1.5 . Micromanipulator Systems
         1.6 . Incubators
         1.7 . Gas Analyzers
         1.8 . Laser Systems
         1.9 . Cryo Systems
        2. Media
      Consumables
        3. Accessories
  • 8.   Global Infertility Treatment Market, By Procedure Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. In Vitro Fertilization
        2. Artificial Insemination
         2.1 . Intrauterine Insemination
         2.2 . Intracervical Insemination
         2.3 . Intratubal Insemination
        3. Fertility Surgery
         3.1 . Laparoscopy
         3.2 . Hysteroscopy
         3.3 . Myomectomy
         3.4 . Laparotomy
         3.5 . Tubal Ligation Reversal
         3.6 . Varicocelectomy
         3.7 . Microsurgical Reconstruction
         3.8 . Vasovasostomy
         3.9 . Vasoepididymostomy
        4. Others
  • 9.   Global Infertility Treatment Market, By Patient Type Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Female Infertility Treatment
        2. Male Infertility Treatment
  • 10.   Global Infertility Treatment Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
    •   1. Fertility Centres
        2. Hospitals and Surgical Clinics
        3. Research Institutes
        4. Cryobanks
  • 11.   North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2020-2027
  • 12.   Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2020-2027
  • 13.   Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2020-2027
  • 14.   Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
  • 15.   Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         15.2.1. GCC
         15.2.2. Israel
         15.2.3. South Africa
         15.2.4. Rest of MEA
        15.3. Market Size (USD Million) Forecast for MEA 2020-2027
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)

    • 16.1 Cook Group Incorporated
                  16.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.1.2. Product Portfolio
                  16.1.3. SWOT Analysis
                  16.1.4. Financial Overview
                  16.1.5. Strategic Overview
          16.2 Esco Micro Pte. Ltd.
                  16.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.2.2. Product Portfolio
                  16.2.3. SWOT Analysis
                  16.2.4. Financial Overview
                  16.2.5. Strategic Overview
          16.3 Genea Limited
                  16.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.3.2. Product Portfolio
                  16.3.3. SWOT Analysis
                  16.3.4. Financial Overview
                  16.3.5. Strategic Overview
          16.4 Hamilton Throne, Ltd.
                  16.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.4.2. Product Portfolio
                  16.4.3. SWOT Analysis
                  16.4.4. Financial Overview
                  16.4.5. Strategic Overview
          16.5 Ihmedical A/S
                  16.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.5.2. Product Portfolio
                  16.5.3. SWOT Analysis
                  16.5.4. Financial Overview
                  16.5.5. Strategic Overview
          16.6 Irvine Scientific (A Member of Jx Holdings Group)
                  16.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.6.2. Product Portfolio
                  16.6.3. SWOT Analysis
                  16.6.4. Financial Overview
                  16.6.5. Strategic Overview
          16.7 IVFTech Aps 
                  16.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.7.2. Product Portfolio
                  16.7.3. SWOT Analysis
                  16.7.4. Financial Overview
                  16.7.5. Strategic Overview
          16.8 Kitazato Corporation
                  16.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.8.2. Product Portfolio
                  16.8.3. SWOT Analysis
                  16.8.4. Financial Overview
                  16.8.5. Strategic Overview
          16.9 Medgyn Products, Inc.
                  16.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.9.2. Product Portfolio
                  16.9.3. SWOT Analysis
                  16.9.4. Financial Overview
                  16.9.5. Strategic Overview
          16.10 Rocket Medical PLC
                  16.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.10.2. Product Portfolio
                  16.10.3. SWOT Analysis
                  16.10.4. Financial Overview
                  16.10.5. Strategic Overview
          16.11 Somatex Medical Technologies GmbH
                  16.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.11.2. Product Portfolio
                  16.11.3. SWOT Analysis
                  16.11.4. Financial Overview
                  16.11.5. Strategic Overview
          16.12 The Baker Company, Inc.
                  16.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.12.2. Product Portfolio
                  16.12.3. SWOT Analysis
                  16.12.4. Financial Overview
                  16.12.5. Strategic Overview
          16.13 The Cooper Companies, Inc.
                  16.13.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.13.2. Product Portfolio
                  16.13.3. SWOT Analysis
                  16.13.4. Financial Overview
                  16.13.5. Strategic Overview
          16.14 Thermo Fisher Scientific 
                  16.14.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.14.2. Product Portfolio
                  16.14.3. SWOT Analysis
                  16.14.4. Financial Overview
                  16.14.5. Strategic Overview
          16.15 Vitrolife Ab
                  16.15.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.15.2. Product Portfolio
                  16.15.3. SWOT Analysis
                  16.15.4. Financial Overview
                  16.15.5. Strategic Overview
          16.16 Zeiss Group
                  16.16.1. Company Overview (HQ, Business Segments, Employee Strength)
                  16.16.2. Product Portfolio
                  16.16.3. SWOT Analysis
                  16.16.4. Financial Overview
                  16.16.5. Strategic Overview

  • 17.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11